Wildcat Capital Management, LLC 13D/13G Filings for UroGen Pharma Ltd. (URGN)

Wildcat Capital Management, LLC 13D and 13G filings for UroGen Pharma Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
4:15 pm
Sale
2021-12-31 13G UroGen Pharma Ltd.
URGN
Wildcat Capital Management, LLC 533,139
2.400%
-719,146decrease
(-57.43%)
Filing
2021-02-12
4:10 pm
Purchase
2020-12-31 13G UroGen Pharma Ltd.
URGN
Wildcat Capital Management, LLC 1,252,285
5.670%
96,423increase
(+8.34%)
Filing